Endogenous interleukin-8 (IL-8) surge in granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization

Blood

Volumn 93, Issue 4, 1999, Pages 1157-1163

  Watanabe, T ^a   Kawano, Y ^b   Kanamaru, S ^b   Onishi, T ^b   Kaneko, S ^b   Wakata, Y ^b   Nakagawa, R ^b   Makimoto, A ^b   Kuroda, Y ^b   Takaue, Y ^b   Talmadge, J E ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; TUMOR NECROSIS FACTOR ALPHA;

APHERESIS; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STEM CELL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0033558301     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.4.1157     Document Type: Article

References (32)

1. To LB, Haylock DN, Simmons PJ, Juttner CA: The biology and clinical uses of blood stem cells. Blood 89:2233, 1997
2. Lane TA, Law P, Maruyama M, Young D, Burgess J, Mullen M, Mealiffe M, Terstappen LWMM, Hardwick A, Moubayed M, Oldham F, Corringham RET, Ho AD: Harvesting and enrichment of hematopoietic progenitor cells mobilized into peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: Potential role in allogeneic marrow transplantation. Blood 85:275, 1995
3. dim) and lymphoid subset, and possible predictors of engraftment and graft-versus-host disease. Blood 86:2842, 1995
4. Tanaka R, Matsudaira T, Aizawa J, Ebihara Y, Muraoka K, Tsuji K, Ikebuchi K, Kodama K, Takaku F, Nakahata T: Characterization of peripheral blood progenitor cells (PBSC) mobilized by filgrastim (rHuG-CSF) in normal volunteers: Dose-effect relationship for filgrastim with the character of mobilized PBSC. Br J Haemalol 92:795, 1996
5. dim progenitor cells during recombinant human granulocyte-colony-stimulating factor administration in normal donors. Transfusion 37:406, 1997
6. Stroncek DF, Clay ME, Smith J, Herr G, Ilstrup S, Kunkel LA, McCullough J: Composition of peripheral blood progenitor cell components collected from healthy donors. Transfusion 37:411, 1997
7. Luster AD: Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338:436, 1998
8. Lévesque JP, Leavesley DI, Niutta S, Vadas M, Simmons PJ: Cytokines increase human hematopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med 181:1805, 1995
9. + progenitor cells from bone marrow and peripheral blood during G-CSF-enhanced recovery. Exp Hematol 23:1535, 1995
10. + cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation. Exp Hematol 26:10, 1998
11. Moore MAS: Clinical implications of positive and negative hematopoietic stem cell regulator. Blood 78:1, 1991
12. Dunlop DJ, Wright EG, Lorimore S, Graham GJ, Holyake T, Kerr DJ, Wolpe SD, Pragnell IB: Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1α in vivo. Blood 79:2221, 1992
13. + progenitors to peripheral blood. J Exp Med 185:111, 1997
14. Lord BI, Woolgford LB, Wood LM, Czaplewski LG, McCount M, Hunter MG, Edwards RM: Mobilization of early hematopoietic progenitor cells with BB10010: A genetically engineered variant of human macrophage inflammatory protein-1α. Blood 85:3412, 1995
15. Marshall E, Woolford LB, Lord BI: Continuous infusion of macrophage inflammatory protein MIP-1α enhances leukocyte recovery and hematopoietic progenitor cell mobilization after cyclophosphamide. Br J Cancer 75:1715, 1997
16. Fibbe WE, Hamilton MS, Laterveer LI, Kibbelaar RE, Frederik E, Visser JWM, Willemze R: Sustained engraftment of mice transplanted with IL-1-primed blood-derived stem cells. J Immunol 148:417, 1992
17. Gasparetto C, Smith C, Gillio A, Stoppa AM, Moore MA, O'Reilly R: Enrichment of peripheral blood stem cells in a primate model following administration of a single dose of rh-IL-1 beta. Bone Marrow Transplant 14:717, 1994
18. Krenger W, Ferrara LM: Dysregulation of cytokines during graft-versus-host disease. J Hematothr 5:3, 1996
19. Andrew RG, Briddell R, Knitter GH, Opie T, Bronsden M, Myerson D, Appelbaum FR, McNiece IK: In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons: Enhanced circulation of progenitor cells. Blood 84:800, 1994
20. Molineux G, McCrea C, Yan XO, Kerzic P, McNiece I: Flt-3 ligand synergizes with granulocyte colony-stimulating factor to increase neutrophil numbers and to mobilize peripheral blood stem cells with long-term repopulating potential. Blood 89:3998, 1997
21. Detmers PA, Powell DE, Walz A, Clark Lewis I, Baggiolini M, Cohn ZA: Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis. J Immunol 147:4211, 1991
22. Papayannoupoulou T, Craddock C: Homing and trafficking of hematopoietic progenitor cells. Acta Haematol 97:97, 1997
23. Laterveer L, Zijlmans JM, Lindley IJ, Hamilton MS, Willemze R, Fibbe WE: Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor. Exp Hematol 24:1387, 1996
24. Wang J, Mukaida N, Zhang Y, Ito T, Nakao S, Matsushima K: Enhanced mobilization of hematopoietic progenitor cells by mouse MIP-2 and granulocyte colony-stimulating factor in mice. J Leukoc Biol 62:503, 1997
25. Laterveer L, Lindley IJD, Heemskerk DPM, Camps JAJ, Pauwels EKJ, Willemze R, Fibbe WE: Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood 87:781, 1996
26. Van Pelt L, Huisman MV, Weening RS, Von dem Borne AEGKR, Roos D, Van Oers RHJ: A single dose of granulocyte-macrophage colony-stimulating factor induces systemic interleukin-8 release and neutrophil activation in healthy volunteers. Blood 87:5305, 1996
27. Geissler K, Peschel C, Niederwieser D, Strobl H, Goldschmitt J, Öhler L, Bettelheim P, Kalhs P, Huber C, Lechner K, Höcker P, Kolbe K: Potentiation of granulocyte colony-stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3. Blood 87:2732, 1996
28. Basser RL, Rasko JEJ, Clarke K, Cebon J, Green MD, Grigg AP, Zalcberg J, Cohen B, O'Byrne J, Menchaca DM, Fox RM, Begley G: Randomized, blind, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer. Blood 89:3118, 1997
29. Papayannopoulou T, Nakamoto B: Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci USA 90:9374, 1993
30. Van Zee KJ, Fischer E, Hawes AS, Hébert CA, Terrell TG, Baker JB, Lowry SF, Moldawer LL: Effects of intravenous IL-8 administration in nonhuman primates. J Immunol 148:1746, 1992
31. + cells in normal donors treated with filgrastim. Transfusion 37:507, 1997
32. + cell counts to guide timing and yield of large-scale collection by leukapheresis. J Hematother 7:45, 1998